Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 198 adverse event reports in the FDA FAERS database where TYSABRI was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for TYSABRI

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 811 9.9% 8 241
Fatigue 759 9.2% 0 56
Malaise 523 6.4% 1 37
Gait disturbance 445 5.4% 2 32
Multiple sclerosis 443 5.4% 9 57
Memory impairment 422 5.1% 0 26
Headache 368 4.5% 0 34
Drug ineffective 329 4.0% 2 25
Asthenia 328 4.0% 3 49
Fall 324 4.0% 8 99
Nasopharyngitis 310 3.8% 0 14
Urinary tract infection 308 3.8% 12 117
Pain 274 3.3% 1 37
Balance disorder 260 3.2% 1 25
Hypoaesthesia 259 3.2% 0 32

Other Indications for TYSABRI

Multiple sclerosis (7,629) Product used for unknown indication (190) Crohn's disease (157) Maternal exposure timing unspecified (15) Exposure via father (5)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

TYSABRI Full Profile All Relapsing-remitting multiple sclerosis Drugs TYSABRI Demographics TYSABRI Timeline